Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.

Benign Prostatic Hyperplasia (BPH)Overactive Bladder

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

J Urol.

Kaplan SA, Herschorn S, McVary KT, Staskin D, Chapple C, Foley S, Cambronero Santos J, Kristy RM, Choudhury N, Hairston J, Schermer CR

doi: 10.1097/JU.0000000000000738.

Lower Urinary Tract Symptoms

Tamsulosin and placebo versus tamsulosin and tadalafil in male lower urinary tract symptoms: A double-blinded, randomized controlled trial

BJU Int.

Nagasubramanian S, John NT, Antonisamy B, Mukha RP, Chandrasingh J, Kumar S, Devasia A, Kekre NS

doi: 10.1111/bju.15027.

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

BJU Int

Roehrborn CG, Manyak MJ, Palacios-Moreno JM, Wilson TH, Roos EP, Santos JC, Karanastasis D, Plastino J, Giuliano F, Rosen RC.

doi: 10.1111/bju.14057.

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): a post hoc analysis of a prospective randomized placebo-controlled study

Int J Clin Pract.

Rosen RC, Roehrborn CG, Manyak MJ, Palacios-Moreno JM, Wilson TH, Lulic Z, Giuliano F

doi: 10.1111/ijcp.13282.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Eur Urol.

Dahm P, Brasure M, MacDonald R, Olson CM, Nelson VA, Fink HA, Rwabasonga B, Risk MC, Wilt TJ

doi: 10.1016/j.eururo.2016.09.032.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review

Aging Male.

MacDonald R, Brasure M, Dahm P, Olson CM, Nelson VA, Fink HA, Risk MC, Rwabasonga B, Wilt TJ

doi: 10.1080/13685538.

Lower Urinary Tract Symptoms

Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms

Eur Urol.

Serati M, Andersson KE, Dmochowski R, Agrò EF, Heesakkers J, Iacovelli V, Novara G, Khullar V, Chapple C

doi: 10.1016/j.eururo.2018.09.029.

Overactive Bladder

International Phase III, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR

J Urol.

Staskin D, Frankel J, Varano S, Shortino D, Jankowich R, Mudd PN Jr

doi: 10.1097/JU.0000000000000807.

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

Menopause.

Kroll R, Archer DF, Lin Y, Sniukiene V, Liu JH

doi: 10.1097/GME.

Related content